Time Investment for Program Implementation to Manage Neuropsychiatric Symptoms: An Observational Longitudinal Study in In-Home and Residential Care Settings [0.03%]
纵向观察研究：居家和机构照料环境中精神行为症状管理项目的实施时间投入分析
Miharu Nakanishi,Junko Niimura,Canan Ziylan et al.
Miharu Nakanishi et al.
Background: There are no studies on how the same psychosocial dementia care program is adapted to both in-home and residential care settings. Objective: ...
Emilio Franco-Macías,Silvia Rodrigo-Herrero,Andrea Luque-Tirado et al.
Emilio Franco-Macías et al.
Background: Memory tests focused on binding may be more sensitive to diagnose Alzheimer's disease (AD) at an early phase. TMA-93 examines relational binding by images. ...
Alzheimer's Disease and Herbal Combination Therapy: A Comprehensive Review [0.03%]
中药复方治疗阿尔茨海默病的研究进展及展望
Sushma Pradeep,Anisha S Jain,Chandan Dharmashekara et al.
Sushma Pradeep et al.
Alzheimer's disease (AD) was first described in 1907 and got its name after Alois Alzheimer, a German psychiatrist and neuropathologist. This disease starts slow, increasing gradually to worsen in the due course of time. AD is mainly charac...
Awareness of Functional Status: People with Alzheimer's Disease Abilities to Self-Report Impairment in Activities of Daily Living [0.03%]
阿尔茨海默病患者对日常生活活动障碍的自我报告能力
Paula Gasparini Emery Trindade,Raquel Luiza Santos,Aud Johannessen et al.
Paula Gasparini Emery Trindade et al.
Background: Awareness of functional status may underlie specific profiles and differences related to stage severity in individuals with Alzheimer's disease (AD). ...
Association Between Serum Magnesium Levels and Alzheimer's Disease or Mixed Dementia Patients: A Population-Based Retrospective Controlled Study [0.03%]
基于人群的回顾性对照研究中镁水平与阿尔茨海默病或混合型痴呆之间的关系
Sara Ben Zaken,Zorian Radomysky,Gideon Koren
Sara Ben Zaken
Background: High magnesium intake has been associated with a decreased risk of dementia. In contrast, other research has found that both low and high serum magnesium levels were associated with an increased risk of Alzhei...
Effects of Ferulic Acid and Angelica archangelica Extract (Feru-guard ®) on Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Prospective Trial [0.03%]
金丝桃素和欧白芷提取物（Feru-guard®）对轻度认知障碍的影响：一项多中心、随机、双盲、安慰剂对照的前瞻性试验
Chiaki Kudoh,Tomokatsu Hori,Shunji Yasaki et al.
Chiaki Kudoh et al.
We conducted a multicenter, randomized, double-blind, placebo-controlled prospective trial examining a supplement containing ferulic acid and Angelica archangelica extract (Feru-guard ®) for mild cognitive impairment (MCI). In the intentio...
The Association Between Anemia of Chronic Inflammation and Alzheimer's Disease and Related Dementias [0.03%]
慢性炎症性贫血与阿尔茨海默病及相关痴呆之间的关联
Alexander Andreev,Burak Erdinc,Kiran Shivaraj et al.
Alexander Andreev et al.
Background: Dementia is a spectrum of neurological diseases characterized by memory impairment and cognitive decline with the pathogenesis and effective management remaining elusive. Several studies have identified a corr...
Alignment of Alzheimer's Disease Amyloid-β Peptide and Herpes Simplex Virus-1 pUL15 C-Terminal Nuclease Domain [0.03%]
淀粉样蛋白-β肽和单纯疱疹病毒-1末端核酶结构域的同源模建及分子对接研究
Steven Lehrer,Peter H Rheinstein
Steven Lehrer
Background: The cause of Alzheimer's disease (AD) is poorly understood. Neurotropic microbes, particularly herpesviruses, might set off chronic neuroinflammation. Amyloid-β (Aβ) has antimicrobial properties and could re...
Neurogenesis Makes a Crucial Contribution to the Neuropathology of Alzheimer's Disease [0.03%]
神经发生对阿尔茨海默病神经病理学的贡献至关重要
John K Young
John K Young
One unexplained feature of Alzheimer's disease (AD) is that the lateral entorhinal cortex undergoes neurodegeneration before other brain areas. However, this brain region does not have elevated levels of amyloid peptides in comparison with ...
Effects of a Nutritional Formulation Containing Caprylic and Capric Acid, Phosphatidylserine, and Docosahexaenoic Acid in Streptozotocin-Lesioned Rats [0.03%]
含辛酸、癸酸、磷脂酰丝氨酸和二十二碳六烯酸营养配方对链脲佐菌素损伤大鼠的效果研究
Eric L R Moura,Hellin Dos Santos,Ana Paula M Celes et al.
Eric L R Moura et al.
Background: It has been studied that nutrition can influence Alzheimer's disease (AD) onset and progression. Some studies on rodents using intraventricular streptozotocin (STZ) injection showed that this toxin changes cer...